Tampa, FL 的 頭頸部鱗狀細胞癌 臨床試驗
15 項針對 頭頸部鱗狀細胞癌 的研究正在 Tampa（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
招募中2/3 期
- Site #0105, Tampa
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
招募中1 期
- Exelixis Clinical Site #8, Tampa
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
招募中1 期
- ALX Center 7, Tampa
JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC
招募中3 期
- Moffitt Cancer Center, Tampa
A Study of JNJ-90301900 in Combination With Chemoradiation Therapy in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma
招募中1 期
- Moffit Cancer center, Tampa
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
招募中2 期
- Moffitt Cancer Center-International Plaza, Tampa
- Moffitt Cancer Center - McKinley Campus, Tampa
- Moffitt Cancer Center, Tampa
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
招募中2 期
- Moffitt Cancer Center-International Plaza, Tampa
- Moffitt Cancer Center - McKinley Campus, Tampa
- Moffitt Cancer Center, Tampa
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
招募中2 期
- Moffitt Cancer Center-International Plaza, Tampa
- Moffitt Cancer Center - McKinley Campus, Tampa
- Moffitt Cancer Center, Tampa
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
招募中1/2 期
- Moffitt Cancer Center, Tampa
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
招募中3 期
- Moffitt Cancer Center, Tampa
A Phase II Study of ACR-368 and Low Dose Gemcitabine in R/M HNSCC
招募中2 期
- Moffitt Cancer Center, Tampa
A Study of ASP-1929 Photoimmunotherapy in Combination With Pembrolizumab in First-line Treatment of Locoregional Recurrent Squamous Cell Carcinoma of the Head and Neck With No Distant Metastases
招募中3 期
- Tampa General Hospital, Tampa
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
招募中1/2 期
- Moffitt Cancer Center, Tampa
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
招募中1 期
- H. Lee Moffitt Cancer Center and Research Institute, Inc, Tampa
Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067
招募中1/2 期
- Moffitt Cancer Center, Tampa
其他城市的 頭頸部鱗狀細胞癌 試驗
- Houston, TX47 項研究
- Los Angeles, CA42 項研究
- Boston, MA40 項研究
- Nashville, TN39 項研究
- New York City, NY39 項研究
- St. Louis, MO28 項研究
- Arlington, VA26 項研究
- Chicago, IL26 項研究
- Philadelphia, PA26 項研究
- Atlanta, GA24 項研究
- San Antonio, TX22 項研究
- Pittsburgh, PA22 項研究
Tampa 的其他研究
- 非小細胞肺癌51 項研究
- 乳癌43 項研究
- 癌症（所有類型）39 項研究
- 大腸直腸癌34 項研究
- 急性髓系白血病29 項研究
- 轉移性癌症29 項研究
- 肺癌29 項研究
- 胰臟癌26 項研究
- 卵巢癌21 項研究
- 黑色素瘤19 項研究
- 骨髓增生異常症候群19 項研究
- 前列腺癌18 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。